In ASCVD, moderate-intensity statin plus ezetimibe was noninferior to high-intensity statin alone at 3 y

被引：0
|
作者：
Kelsey, Michelle D. [1 ]
Newby, L. Kristin
机构：
[1] Duke Univ, Durham, NC 27708 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 11期
关键词：
D O I：
10.7326/J22-0085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC126 / JC126
页数：1
相关论文
共 50 条
  • [21] Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy
    Li, Sha
    Liu, Hui-Hui
    Li, Jian-Jun
    DRUGS, 2025, 85 (01) : 51 - 65
  • [22] High-intensity versus moderate-intensity statin treatment for patients with ischemic stroke: Nationwide cohort study
    Bach, Frederikke
    Skajaa, Nils
    Esen, Buket Ozturk
    Fuglsang, Cecilia Hvitfeldt
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    Adelborg, Kasper
    EUROPEAN STROKE JOURNAL, 2023, 8 (04) : 1041 - 1052
  • [23] Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial
    Lee, Yong-Joon
    Lee, Sang-Hyup
    You, Seng Chan
    Lee, Yong-ho
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Jung-Sun
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 829 - 839
  • [24] Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events
    Godoy, L. C.
    Kiflen, M.
    Alonzo, R.
    Chu, A.
    Austin, P. C.
    Fang, J.
    Basque, S.
    Lawler, P. R.
    Nunes, J. T.
    Jackevicius, C. A.
    Ko, D. T.
    Lee, D. S.
    Goodman, S. G.
    Farkouh, M. E.
    Udell, J. A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Safety and efficacy of moderate-intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease
    Cha, Jung-Joon
    Kim, Ju Hyeon
    Hong, Soon Jun
    Lim, Subin
    Joo, Hyung Joon
    Park, Jae Hyoung
    Yu, Cheol Woong
    Lee, Pil Hyung
    Lee, Seung Whan
    Lee, Cheol Whan
    Moon, Jae Youn
    Lee, Jong-Young
    Kim, Jung-Sun
    Park, Jae Suk
    Lim, Do-Sun
    JOURNAL OF INTERNAL MEDICINE, 2025, 297 (04) : 400 - 408
  • [26] Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
    Ballantyne, Christie M.
    Ditmarsch, Marc
    Kastelein, John J. P.
    Nelson, Adam J.
    Kling, Douglas
    Hsieh, Andrew
    Curcio, Danielle L.
    Maki, Kevin C.
    Davidson, Michael H.
    Nicholls, Stephen J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (04) : 491 - 503
  • [27] Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease A Post Hoc Analysis From the RACING Randomized Clinical Trial
    Lee, Seung-Jun
    Cha, Jung-Joon
    Choi, Woong Gil
    Lee, Wang-Soo
    Jeong, Jin-Ok
    Choi, Seonghoon
    Cho, Yoon-Haeng
    Park, Woojung
    Yoon, Chang-Hwan
    Lee, Yong-Joon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Hong, Soon Jun
    Kim, Jung-Sun
    JAMA CARDIOLOGY, 2023, 8 (09) : 853 - 858
  • [28] High-intensity versus low- or moderate-intensity statin treatment for patients with ischemic stroke: Nationwide cohort study
    Bach, Frederikke
    Skajaa, Nils
    Esen, Buket Ozturk
    Fuglsang, Cecilia
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    Adelborg, Kasper
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 75 - 76
  • [29] Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study
    Juwon Kim
    Danbee Kang
    Hyejeong Park
    Minwoong Kang
    Ki Hong Choi
    Taek Kyu Park
    Joo Myung Lee
    Jeong Hoon Yang
    Young Bin Song
    Jin-Ho Choi
    Seung-Hyuk Choi
    Hyeon-Cheol Gwon
    Eliseo Guallar
    Juhee Cho
    Joo-Yong Hahn
    Cardiovascular Drugs and Therapy, 2023, 37 : 141 - 150
  • [30] COST-EFFECTIVENESS OF ALIROCUMAB IN COMBINATION WITH HIGH-INTENSITY STATIN AND EZETIMIBE IN ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) IN TAIWAN
    Tan, E. C. H.
    Yang, C. L.
    VALUE IN HEALTH, 2024, 27 (12)
12345